In Stock, Ready to Ship!
$60.00
99% Pure | USA Made | Multi DoseHexarelin is a synthetic six-amino-acid peptide that binds the ghrelin receptor (GHS-R1a) to trigger robust, reproducible growth-hormone (GH) pulses and cardioprotective signaling in vitro and in vivo. In cardiac-cell and rodent models, Hexarelin enhances GH and IGF-1 release, supports coronary endothelial function, and models anti-apoptotic pathways. Each 5 mg vial is USA-manufactured, HPLC-verified to ≥ 99% purity, and endotoxin-screened (< 0.1 EU/mg), delivering clean, reliable data for GH-axis and cardiovascular research.
Peptides are not ready to use. Must purchase BAC water for reconstitution.
Hexarelin peptide induces swift GH peaks within 20–30 minutes, enabling precise mapping of downstream IGF-1 dynamics.
Drives reproducible IGF-1 upregulation in hepatocyte and cardiac myocyte assays, supporting anabolic- and cardioprotective studies.
In endothelial-cell cultures, Hexarelin enhances nitric-oxide production and reduces apoptosis under hypoxic stress.
In muscle-cell assays, it boosts protein-synthesis markers (e.g., AKT/mTOR), modeling anabolic signaling.
Short half-life (~ 45 minutes) allows repeated dosing to dissect somatostatin feedback without receptor desensitization.
Reconstitute in sterile or bacteriostatic water; store powder at – 20 °C and solution at 2–8 °C for up to 7 days.
Hexarelin is a synthetic GH-releasing peptide that directly activates the ghrelin receptor (GHS-R1a) on pituitary and cardiac cells. Unlike broader secretagogues, Hexarelin provokes strong, reproducible GH surges and engages cardioprotective pathways, making it an ideal research tool for studying both endocrine and cardiovascular models under tightly controlled laboratory conditions.
Researchers select Hexarelin when they need a dual-action peptide that delivers both robust GH-release and cardioprotective signaling. Its ability to generate clean GH pulses—without significant cortisol or prolactin spikes—combined with demonstrated benefits in endothelial-cell and hypoxia assays makes it uniquely versatile. Manufactured under ISO-certified conditions and verified to ≥ 99% purity with stringent endotoxin screening, Hexarelin provides reproducible, high-fidelity data for hormone-axis and cardiovascular-health research.
Hexarelin stands out by combining potent GH-axis activation with direct cardiac-cell effects. Its six-residue sequence ensures rapid receptor engagement for growth-hormone release, while also triggering anti-apoptotic and vasodilatory pathways in heart-related models. This unique dual-pathway action—paired with a clean, short-acting profile—allows researchers to dissect endocrine and cardiovascular mechanisms in a single peptide, streamlining study design and enhancing translational relevance.
To study GH-release dynamics, IGF-1 signaling, and cardioprotective pathways in cell and animal models.
GH peaks occur within 20–30 minutes after dosing in culture or rodent assays.
Enhances nitric-oxide production and reduces apoptosis under hypoxic stress, modeling cardiac protection.
Yes—GH surges induced by Hexarelin lead to consistent IGF-1 increases in hepatic and muscle assays.
In vitro: 100 nM–1 µM; in vivo rodent: 0.1–1 mg/kg, per protocol.
Dissolve in Sterile Water for Injection (SWFI) or Bacteriostatic Water (BAC) and mix gently until clear.
Store lyophilized at – 20 °C; keep reconstituted solution at 2–8 °C and use within 7 days.
It provokes GH without significant cortisol or prolactin elevation—ensuring GH-axis–specific data.
Can Hexarelin be combined with GHRH analogs?
Real Peptides offers ISO-certified, USA-manufactured Hexarelin (5 mg), ≥ 99% purity, and low endotoxin—available for research use only.
Don't hestitate to contact us
End of Content.
